Latest BD News & Updates

See the latest news and media coverage for BD. We track all announcements, press releases, and industry mentions in real time, all in one place.

BD

Global medical technology company

bd.com

Headquarters: Franklin Lakes, United States
Company type: Public company
Number of employees: 45,000+
Industry: Medical Equipment, Supplies & Distribution

Last updated Today

Latest news about BD

In short: BD reported 5.4% revenue growth in Q3 fiscal 2026, launched several medical technologies, and issued a recall for intraosseous needle sets.

Company announcements

August 6 BD

BD reports third quarter fiscal 2026 financial results with revenue growth and updated guidance

Revenue increased 5.4% to $5.0 billion, driven by strong performance across Medical Essentials and Interventional segments.

July 22 BD

BD EVP Mike Garrison retires after 20 years

He led Medical Essentials and BioPharma Systems segments, effective Oct 2.

June 23 BD

BD awarded Vizient Innovative Technology contract for CentroVena One

The all-in-one central line insertion system simplifies procedures with fewer steps and enhances patient and clinician safety.

May 7 BD

BD appoints Vitor Roque CFO

Roque, interim CFO since December 2025, has over 25 years at BD in senior finance roles. He advances the New BD strategy and financial performance.

Media coverage

Yesterday The Gridley Herald

... Claims - If you purchased Becton, Dickinson and Company common stock (BD)...

Local newspaper covering the Gridley region in the heart of California | Press Releases...

September 2 U.S. Food and Drug Administration

Medline Issues Correction for Convenience Kits

Certain BD ChloraPrep Applicators in Convenience Kits manufactured by Medline may not be sterile.

August 14 Seeking Alpha

Starboard adds Dynatrace, Flowserve, and exits Beckton Dickson, among top Q2 trades

Starboard Value’s latest 13F reveals new stakes in Dynatrace and Flowserve, exits from BDX and Gen Digital, plus key trims—read the update now.

August 12 Medical Device Network

Enrolment concludes in BD’s PREVENT trial of Phasix Mesh

BD has completed patient enrolment in the PREVENT clinical trial, which is evaluating the use of Phasix Mesh for preventing incisional hernias.

Never miss news about BD

Track BD and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

BD competitors & trending companies

Browse news for competitors to BD and other trending companies.